For the quarter ending 2025-09-30, IPSI had -$13,169 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -22,208,361 | -24,321,064 |
| Derivative liability movements | -33,292,940 | 2,635,208 |
| Depreciation | 543 | 1,084 |
| Amortization of debt discount | 48,534 | 178,491 |
| Loss on settlement and repricing of convertible notes | -23,653,503 | 17,686,534 |
| Fair value of price protected warrants | 0 | 8,250,469 |
| Fair value of common shares issued for services | 296,750 | - |
| Deemed interest income | 10,188 | 18,658 |
| Stock based compensation | 1,371 | 19,186 |
| Other current assets | 42,535 | 6,995 |
| Accounts payable and accrued expenses | -28,301 | 12,417 |
| Related party payables | 2,726 | 5,106 |
| Interest receivable | 3,629 | 7,141 |
| Interest accruals | 232,357 | 437,656 |
| Unrealized loss on equity method investments | 0 | 0 |
| Warrants issued for services | 0 | 0 |
| Receivable from equity method investments | 0 | 0 |
| Cash used in operating activities | -137,358 | -398,123 |
| Proceeds from bank overdraft | - | 811 |
| Proceeds from convertible notes | 125,000 | 417,000 |
| Proceeds from notes payable | 0 | 0 |
| Repayment of convertible notes | 0 | 0 |
| Net cash provided by financing activities | 124,189 | 417,811 |
| Investment in notes receivable | 0 | 0 |
| Investment in equity method investment | 0 | 0 |
| Cash used in investing activities | 0 | 0 |
| Net increrase (decrease) in cash | -13,169 | 19,688 |
| Cash and cash equivalents at beginning of period | 526 | - |
| Cash and cash equivalents at end of period | 7,045 | - |
Innovative Payment Solutions, Inc. (IPSI)
Innovative Payment Solutions, Inc. (IPSI)